Efficacy and Safety of Rivaroxaban Compared with Other Therapies ...

RIV plus ASA is associated with reduced risk of revascularization compared with ASA monotherapy, but the evidence for other comparators, in particular ...

Evaluation of the efficacy and safety of rivaroxaban compared to ...

The trial demonstrated that rivaroxaban is as effective as warfarin in terms of thrombus resolution rate, reduction in thrombus size, bleeding risk, and ...

Comparative effectiveness of rivaroxaban in the treatment of ...

When the odds of major or clinically relevant bleeding in each study were compared with each other, the risk was 34% lower in apixaban compared with rivaroxaban ...

Efficacy and safety of rivaroxaban versus warfarin in the ... - Frontiers

Conclusion: Compared with warfarin, rivaroxaban exhibited comparable efficacy for the anticoagulant treatment of unusual site DVT, associated ...

Efficacy and Safety of Rivaroxaban Compared With Warfarin Among ...

Among older patients, 59.4% of patients on warfarin and 59.3% of patients on rivaroxaban completed the trial taking their assigned treatment compared with 69.9% ...

Head-to-head efficacy and safety of rivaroxaban, apixaban, and ...

Patients treated with rivaroxaban demonstrated lower rate of intracranial haemorrhage compared with apixaban (HR,0.86; 95% CI,0.74–1.0; P,0.044). The rate of ...

Efficacy and Safety of Rivaroxaban Compared With Warfarin Among ...

Elderly patients had higher stroke and major bleeding rates than younger patients, but the efficacy and safety of rivaroxaban relative to warfarin did not ...

Efficacy and Safety of Rivaroxaban versus Warfarin for the ...

We previously compared rivaroxaban monotherapy with standard therapy based on gene testing to adjust the dose of warfarin [2]. The results ...

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

The efficacy of rivaroxaban, as compared with warfarin, was as favorable in centers with the best INR control as in those with poorer control.

Efficacy and Safety of Rivaroxaban Therapy for Patients With ...

Compared with control, rivaroxaban therapy did not reduce the risks of myocardial infarction (0.87, 0.73 to 1.04, p = 0.12), ischemic stroke ( ...

Efficacy and Safety of Combination Therapy with Low-Dose ... - MDPI

These studies showed that low-dose rivaroxaban 2.5 mg bid (LDR) plus ASA reduced the rate of cardiovascular events compared to the antiplatelet regimen alone, ...

Efficacy and safety of rivaroxaban compared with warfarin in patients ...

The efficacy of rivaroxaban when compared with warfarin for the prevention of stroke or systemic embolism was similar in patients with PAD (HR: ...

Comparison of the efficacy and safety of rivaroxaban and low ...

Rivaroxaban might be a promising alternative to LMWH as initial treatment for nonhigh-risk PE in lung cancer patients.

Evaluating the efficacy and safety of rivaroxaban as a warfarin ...

Most studies conducted to compare the safety and efficacy of rivaroxaban and warfarin have been conducted on PE and DVT patients. Clinical trials evaluating ...

Safety and Effectiveness of Rivaroxaban Versus Warfarin Across ...

Compared to warfarin, rivaroxaban was associated with greater or similar effectiveness across a broad range of kidney function (pooled HRs of 0.72 [95% CI, 0.66 ...

Efficacy and safety of novel oral anticoagulants for treatment of acute ...

Rivaroxaban reduced the risk of major bleeding compared with conventional treatment (0.57, 0.39 to 0.84), whereas other novel oral ...

Efficacy and Safety of Rivaroxaban for Extremely Aged Patients with ...

Key conclusions: Patients with infection should be more careful of bleeding events during rivaroxaban therapy. An age-adjusted Charlson ...

Evaluating the efficacy and safety of rivaroxaban as a warfarin ...

Rivaroxaban may be as effective as warfarin in treating CTEPH patients after endarterectomy in the short term and can be used as an anticoagulant in these ...

Efficacy and safety of rivaroxaban compared with other therapies ...

There was no evidence for differences between RIV plus ASA and dual antiplatelet therapy and vitamin K antagonists plus ASA. Similar results ...

A Systematic Literature Review and Network Meta-Analysis. - EBSCO

Efficacy and Safety of Rivaroxaban Compared with Other Therapies Used in Patients with Peripheral Artery Disease Undergoing Peripheral Revascularization: A ...